5-fluorouracil in the treatment of scleroderma: a randomised, double blind, placebo controlled international collaborative study.
about
Targeted Therapy in Systemic SclerosisCurrent treatment options in systemic Sclerosis (Scleroderma).A review of Campath in autoimmune disease: biologic therapy in the gray zone between immunosuppression and immunoablation.Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial.
P2860
5-fluorouracil in the treatment of scleroderma: a randomised, double blind, placebo controlled international collaborative study.
description
1990 nî lūn-bûn
@nan
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
5-fluorouracil in the treatmen ...... rnational collaborative study.
@ast
5-fluorouracil in the treatmen ...... rnational collaborative study.
@en
5-fluorouracil in the treatmen ...... rnational collaborative study.
@nl
type
label
5-fluorouracil in the treatmen ...... rnational collaborative study.
@ast
5-fluorouracil in the treatmen ...... rnational collaborative study.
@en
5-fluorouracil in the treatmen ...... rnational collaborative study.
@nl
prefLabel
5-fluorouracil in the treatmen ...... rnational collaborative study.
@ast
5-fluorouracil in the treatmen ...... rnational collaborative study.
@en
5-fluorouracil in the treatmen ...... rnational collaborative study.
@nl
P2093
P2860
P356
P1476
5-fluorouracil in the treatmen ...... rnational collaborative study.
@en
P2093
Alarcón GS
Blackburn WD
Escudero EE
Menajovsky BL
Subauste CP
Villarreal I
P2860
P304
P356
10.1136/ARD.49.11.926
P407
P577
1990-11-01T00:00:00Z